We are live on ! Find out more
KALA icon

KALA BIO

28 hedge funds and large institutions have $12.8M invested in KALA BIO in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

843% more capital invested

Capital invested by funds: $1.36M → $12.8M (+$11.5M)

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0.44% more ownership

Funds ownership: 0%0.44% (+0.44%)

47% less funds holding

Funds holding: 5328 (-25)

81% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 31

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2.38M

Holders
28
Holders Change
-25
Holders Change %
-47.17%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
8
Reduced
6
Closed
31
Calls
Puts
$2.38M
Net Calls
-$2.38M
Net Calls Change
-$2.38M

KALA Hedge Fund Activity: Q4 2022 in Review

28 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2022, worth a combined $12.8M — up 843% from $1.36M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of KALA and 6 opened new positions — a net loss of 25 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $608K. The largest seller was Vanguard Group, cutting an estimated $107K.

  • 28 institutional investors held KALA BIO (KALA) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $12.8M of KALA BIO stock for Q4 2022, up 843% quarter-over-quarter.
  • 6 funds opened new KALA BIO positions in Q4 2022 and 31 closed out, a net change of -25 holders.
  • The largest KALA BIO buyer in Q4 2022 was Baker Bros. Advisors, an estimated $608K added.
  • The largest KALA BIO seller in Q4 2022 was Vanguard Group, an estimated $107K sold.

Based on aggregated 13F filings for Q4 2022.